Fig. 1From: A deconvolution method and its application in analyzing the cellular fractions in acute myeloid leukemia samplesFlowchart of LinDeconSeq in identifying marker genes and predicting cellular fractions for bulk samples. The procedure has two stages. In stage 1, a set of marker genes are identified and allocated to the cell types. In stage 2, a weighted RLM with the signature matrix is derived from high confidence marker genes (identified in stage 1) and is used to predict the cellular fractions for bulk samplesBack to article page